INTERNATIONAL PATENT: CHUGAI SEIYAKU KABUSHIKI KAISHA, 中外製薬株式会社, KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION, 京都府公立大学法人 FILES APPLICATION FOR "MOLECULAR TARGETED DRUG COMBINATION THERAPY IN CANCER PATIENTS HAVING DRIVER MUTATION"

Posted On: 2025-04-20

GENEVA, April 20 -- CHUGAI SEIYAKU KABUSHIKI KAISHA (5-1, Ukima 5-chome, Kita-ku, Tokyo1158543), 中外製薬株式会社 (東京都北区浮間５丁目５番１号), KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION (465, Kajii-cho, Kawaramachi-dori Hirokoji-agaru, Kamigyo-ku, Kyoto-shi, Kyoto6028566), 京都府公立大学法人 (京都府京都市上京区河原町通広小路上る梶井町４６５) filed a patent application (PCT/JP2024/036536) for "MOLECULAR TARGET...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: CHUGAI SEIYAKU KABUSHIKI KAISHA, 中外製薬株式会社, KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION, 京都府公立大学法人 FILES APPLICATION FOR "MOLECULAR TARGETED DRUG COMBINATION THERAPY IN CANCER PATIENTS HAVING DRIVER MUTATION"